Recently, Anthropic has been vigorously driving the acquisition, investment, and collaboration of AI-biotech companies by recruiting industry leaders. Its business endeavors span multiple areas, including drug discovery and clinical development. The company acquired Coefficient Bio, a startup established just eight months ago, for roughly $400 million in stock. Coefficient Bio's team will now be integrated into Anthropic's healthcare and life sciences division. Furthermore, Anthropic has unveiled the Claude Science research workbench, which consolidates research tools and leverages professional models. At the same time, the company has released a preview of the MHS model hardware standard research. This initiative aims to standardize device control interfaces, lower the costs associated with accessing and coordinating experimental execution, and enhance the execution environment. By doing so, it facilitates the transfer of model capabilities across software, computing, and devices. The acquisition provides Anthropic with specific laboratory expertise, and its recruitment criteria reflect a strong emphasis on well-established experimental processes and professional teams. The research workbench and device interfaces are designed to work in tandem. While the open MHS interface alleviates concerns about collaboration, it also opens the door for the utilization of other models. Moving forward, attention will need to be directed toward the system's reusability and the time savings it offers to researchers.